Global Dermatology Market to 2022


Posted December 14, 2016 by Shirley

Global Dermatology Market to 2022 – Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth is a professional and in-depth study.
 
MRRS adds "Global Dermatology Market to 2022 – Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth" latest studies, published in November 2016. It is a professional and in-depth study.

Summary
Dermatological conditions are one of the most common types of disorders worldwide, and approximately one-third of the US population suffers from at least one active skin condition.For the past decades, the majority of the dermatology market has remained saturated with established products. However, the clinical and commercial success of biologics in the treatment of psoriasis, as well as advancements in the understanding of the disease pathways of many dermatological conditions, have led to a renewed interest from pharmaceutical companies in the dermatology market, and subsequently the emergence of an innovative pipeline.

This report covers all dermatological disorders, but there is a particular focus on three key diseases: atopic dermatitis, acne vulgaris and psoriasis, as these conditions have the highest prevalence and the largest pipeline. The global dermatology market was valued at $20.0 billion in 2015, and is projected to grow at a considerable Compound Annual Growth Rate (CAGR) of 7.73%, reaching $33.7 billion in 2022. Key drivers of this growth will be the uptake of recently approved premium biologics, as well as promising late-stage products that are expected to be highly valuable.

Table of Contents
3 Key Marketed Products 23
3.1 Overview 23
3.2 Humira (adalimumab) 24
3.3 Remicade (infliximab) 26
3.4 Enbrel (etanercept) 27
3.5 Stelara (ustekinumab) 29
3.6 Neoral (cyclosporine) 30
3.7 Protopic (tacrolimus) 32
3.8 Elidel (pimecrolimus) 33
3.9 Elocon (mometasone furoate) 34
3.10 Differin (adapalene) 35
3.11 Metolate (methotrexate) 36
3.12 Clobex (clobetasol propionate) 36
3.13 Conclusion 37
4 Pipeline Landscape Assessment 38
4.1 Overview 38
4.2 Molecule Types in the Pipeline 41
4.3 Molecular Targets in the Pipeline 43
4.4 Clinical Trials 44
4.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target 45
4.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target 48
4.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target 52
4.4.4 Aggregate Clinical Program Size by Stage of Development, Indication, Molecule Type and Molecular Target 56
4.5 Conclusion 61
5 Multi-Scenario Market Forecast to 2022 62......

List of Tables and Figures 
Table 1: Dermatology, Global, Epidemiology of Dermatological Disorders, 2015 15
Table 2: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Humira, 2015 25
Table 3: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Remicade, 2015 26
Table 4: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Enbrel, 2015 28
Table 5: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Stelara, 2015 29
Table 6: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Neoral, 2015 31
Table 7: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Protopic, 2015 32
Table 8: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Elidel, 2015 34
Table 9: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Elocon, 2015 34
Table 10: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Differin, 2015 35
Table 11: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Metolate, 2015 36
Table 12: Dermatology Therapeutics Market, Global, Approved Dermatology Indications for Clobex, 2015 37
Table 13: Dermatology Therapeutics Market, Global, Annual Revenue Forecast for Key Products ($bn), 2015-2022 63.....

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/global-dermatology-market-to-2022-innovative-pipeline-and-increasing-uptake-of-biologics-to-diversify-treatment-options-and-drive-strong-growth

About Market Research Report Store
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.

Ask a sample and any further questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Report Store
Country United States
Categories Business , Marketing , Reports
Last Updated December 14, 2016